supp.fit

Probiotics and Prebiotics: study protocols

66 study groups took Probiotics together with Prebiotics. These are the doses the studies gave. They are not a recommendation.

Probiotics: what the research found →

Dose per serving from research: Probiotics

60 study groups in 56 studies say how much Probiotics participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 billion CFU to 2.5 billion CFU, 20% of 60 study groups.

Daily doseStudy groups
0.05 billion CFU or less
1
0.05 billion CFU to 0.1 billion CFU
3
0.1 billion CFU to 0.25 billion CFU
4
0.25 billion CFU to 0.5 billion CFU
0
0.5 billion CFU to 1 billion CFU
9
1 billion CFU to 2.5 billion CFU
12
2.5 billion CFU to 5 billion CFU
5
5 billion CFU to 10 billion CFU
11
10 billion CFU to 25 billion CFU
9
25 billion CFU to 50 billion CFU
2
50 billion CFU to 100 billion CFU
3
over 100 billion CFU
1

Dose per serving from research: Prebiotics

47 study groups in 43 studies say how much Prebiotics participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 5 g to 10 g, 23% of 47 study groups.

Daily doseStudy groups
50 mg or less
2
50 mg to 100 mg
2
100 mg to 250 mg
5
250 mg to 500 mg
4
500 mg to 1 g
3
1 g to 2.5 g
6
2.5 g to 5 g
9
5 g to 10 g
11
10 g to 25 g
2
25 g to 50 g
1
over 50 g
2

Commonly used together

9 of 66 study groups took Probiotics and Prebiotics with something else, but nothing that 3 or more different studies gave.

66 study groups

Study
Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial
2010 · Prebiotic and probiotic fortified milk (PP) · Children aged 1–4 years in a community setting in India, with no specific diagnosed condition required
0.019 billion CFU2.4 g1 year312
Effects of synbiotics on necrotizing enterocolitis and full enteral feeding in very low birth weight infants: A double-blind, randomized controlled trial
2024 · Synbiotic group · Preterm neonates with very low birth weight under 1500 g and gestational age under 34 weeks
2 billion CFU——59
Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial
2018 · Synbiotics group · Patients older than 16 years with sepsis requiring mechanical ventilation in the ICU
3 g10 g20 days35
Effect of an Immune-Boosting, Antioxidant and Anti-Inflammatory Food Supplement in Hospitalized COVID-19 Patients: A Prospective Randomized Pilot Study
2023 · intervention group · Adults aged 18 years or older hospitalized with PCR-confirmed COVID-19 who required more than 48 hours of admission
1 billion CFU200 mg—78
Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: a randomized, double-blind clinical trial
2015 · group S (synbiotics) · Adults undergoing surgery for periampullary neoplasms; age and sex not specified
8 billion CFU200 mg2 weeks23
A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
2024 · SIM01 · Adults with post-acute COVID-19 syndrome (PACS), with at least one PACS symptom persisting for 4 weeks or more after confirmed SARS-CoV-2 infection
20 billion CFU—26 weeks232
Effectiveness of a Balanced Nine-Strain Synbiotic in Primary-Care Irritable Bowel Syndrome Patients-A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial
2024 · multi-strain synbiotic group · Female and male patients aged 18–65 years with moderate to severe irritable bowel syndrome
4.5 billion CFU—12 weeks101
Effectiveness of Sterilized Symbiotic Drink Containing Lactobacillus helveticus Comparable to Probiotic Alone in Patients with Constipation-Predominant Irritable Bowel Syndrome
2020 · Group A (symbiotic group) · Adults with constipation-predominant irritable bowel syndrome; age range not reported; both sexes
350 mL5.85 g7 days79
The effects of LactoCare synbiotic administration on chemotherapy-induced nausea, vomiting, diarrhea, and constipation in children with ALL: A double-blind randomized clinical trial
2023 · LactoCare-treatment group · Children with acute lymphoblastic leukemia receiving maintenance chemotherapy
10 billion CFU—7 days58
Probiotics combined with prebiotics alleviated seasonal allergic rhinitis by altering the composition and metabolic function of intestinal microbiota: a prospective, randomized, double-blind, placebo-controlled clinical trial
2024 · test group (probiotics and prebiotics) · Adults aged 18–65 with seasonal allergic rhinitis lasting more than 1 year and TNSS greater than 4
8 g60 g90 days53
Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial
2023 · Group D · Adults aged 18–70 with functional constipation
19.2 billion CFU960 mg4 weeks50
Functional response to a microbial synbiotic in the gastrointestinal system of children: a randomized clinical trial
2023 · Active synbiotic arm · Children aged 3–17, male and female, with variable weekly bowel movement frequency; some had low-frequency bowel movements or constipation
10 billion CFU6.2 g12 weeks43
The promising effects of a multi-species synbiotic preparation on metabolic profile in elderly patients with type 2 diabetes and high cardiovascular risk: a randomized, triple-blind, placebo-controlled trial
2025 · Synbiotic group · Men and women aged 65 years or older with type 2 diabetes and high cardiovascular risk
2 billion CFU500 mg120 days43
Effect of a Multispecies Synbiotic Supplementation on Body Composition, Antioxidant Status, and Gut Microbiomes in Overweight and Obese Subjects: A Randomized, Double-Blind, Placebo-Controlled Study
2023 · synbiotic group · Adults aged 18–45 with BMI 23–30 kg/m², classified as overweight or obese
37 billion CFU—12 weeks36
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study
2020 · synbiotic group · Female and male adults aged 18–60 with moderate or severe diarrhea-predominant irritable bowel syndrome (IBS-D)
10 billion CFU1.89 g8 weeks35
The effects of synbiotics supplementation on reducing chemotherapy-induced side effects in women with breast cancer: a randomized placebo-controlled double-blind clinical trial
2023 · Synbiotics · Women aged 18 years or older with breast cancer, no metastasis, undergoing neoadjuvant or adjuvant chemotherapy
2 billion CFU42 g8 weeks34
Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with Functional Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial
2025 · synbiotic group · Adults aged 60 years or older with functional constipation by Rome IV criteria and no significant comorbidities
20 billion CFU800 mg4 weeks34
Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson's disease
2025 · synbiotic group · Adults aged 45–65, both sexes, newly diagnosed with Parkinson's disease, stages 1–4
20 billion CFU6 g90 days33
Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis
2016 · synbiotic group · Adults aged 25–74 with biopsy-confirmed nonalcoholic steatohepatitis (NASH); both sexes
0.2 billion CFU8 g90 days27
Effects of synbiotic supplementation on the components of metabolic syndrome in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial
2024 · Synbiotic + antipsychotic group · Adults aged 18–65 with schizophrenia, BMI ≥23 and at least two metabolic-syndrome criteria, taking antipsychotic drugs
2 billion CFU42 mg8 weeks27
Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation
2014 · Treatment Group (TG) · Adults aged 18–45 years, both sexes, with chronic constipation
2 billion CFU3.6 g2 weeks26
Effects of probiotic and synbiotic supplementation on ponderal and linear growth in severely malnourished young infants in a randomized clinical trial
2023 · Synbiotic · Infants aged 2–6 months with severe acute malnutrition, recovering from acute illness; both sexes
8 billion CFU3.2 g4 weeks23
Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthropometric measures and cardiometabolic traits in women with obesity: a randomized controlled clinical trial
2023 · L-carnitine + synbiotic · Women aged 19–49 with obesity (BMI 30–35 kg/m²), without the listed comorbidities
0.1 billion CFU175 mg8 weeks23
Do synbiotics really enhance beneficial synbiotics effect on defecation symptoms in healthy adults?: Randomized, double-blind, placebo-controlled trial
2022 · Synbiotics · Healthy adults aged 20–60 years, men and women, with bowel movements 2–3 times per week and a tendency to constipation
10 billion CFU1 g2 weeks22
The effect of a new developed synbiotic yogurt consumption on metabolic syndrome components in adults with metabolic syndrome: a randomized controlled clinical trial
2024 · intervention group · Adults aged 30–50 with metabolic syndrome and BMI 25–35 kg/m²
0.2 billion CFU—12 weeks22
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic in Patients with Functional Diarrhea and High Fecal Calprotectin Levels: A Pilot Study
2022 · synbiotic group · Adults with functional diarrhea and fecal calprotectin levels of at least 11.5 mg/kg; mean age 49.8 years
0.1 billion CFU2.4 g8 weeks20
Comparison of the Effects of Prebiotics and Synbiotics Supplementation on the Immune Function of Male University Football Players
2023 · synbiotic group (SG) · Male university football players; age not reported; healthy student-athletes undergoing high-intensity training
14 billion CFU—6 weeks15
Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years
2006 · Synbiotic group · Children aged 2 years and over with moderate or severe atopic dermatitis and a SCORAD score of at least 15
3.6 billion CFU—90 days—
Beneficial effects of a synbiotic supplement on self-perceived gastrointestinal well-being and immunoinflammatory status of healthy adults
2011 · synbiotic product · Healthy adults aged 25–45 years; 20 women and 16 men overall
2.4 billion CFU—6 weeks—
Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study
2011 · synbiotics treatment group · Patients with mild to moderate ulcerative colitis
3 g5.5 g1 year—
Synbiotic in the management of infantile colic: a randomised controlled trial
2014 · synbiotic group · Breastfed infants aged 15–120 days with infantile colic
1 billion CFU—30 days—
Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial
2016 · LU + B420 · Adults aged 18–65 with overweight or obesity (BMI 28.0–34.9)
10 billion CFU12 g26 weeks—
Effect of synbiotic and probiotic supplementation on serum brain-derived neurotrophic factor level, depression and anxiety symptoms in hemodialysis patients: a randomized, double-blinded, clinical trial
2021 · synbiotic · Hemodialysis patients; age and sex not specified
5 g15 g12 weeks—
Effect of synbiotic supplementation on migraine characteristics and inflammatory biomarkers in women with migraine: Results of a randomized controlled trial
2021 · synbiotic · Women with migraine
2 billion CFU—12 weeks—
Effects of Synbiotic Supplementation on Metabolic Syndrome Traits and Gut Microbial Profile among Overweight and Obese Hong Kong Chinese Individuals: A Randomized Trial
2023 · synbiotic supplementation group (SG) · Overweight and obese Hong Kong Chinese individuals aged 20–65 years
20 billion CFU3.4 g8 weeks—
Effects of Synbiotic Supplementation on Metabolic Syndrome Traits and Gut Microbial Profile among Overweight and Obese Hong Kong Chinese Individuals: A Randomized Trial
2023 · dietary intervention with synbiotic supplementation group (DSG) · Overweight and obese Hong Kong Chinese individuals aged 20–65 years
20 billion CFU3.4 g8 weeks—
A young child formula with Limosilactobacillus reuteri and GOS modulates gut microbiome and enhances bone and muscle development: a randomized trial
2025 · experimental young child formula (EYCF) · Healthy Filipino boys and girls aged 24–36 months
0.1 billion CFU—26 weeks91
Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial
2024 · synbiotic group · Women aged 18–45 with newly diagnosed polycystic ovary syndrome (PCOS)
20 billion CFU500 mg12 weeks28
Effects of a Synbiotic Formula on Functional Bowel Disorders and Gut Microbiota Profile during Long-Term Home Enteral Nutrition (LTHEN): A Pilot Study
2020 · intervention group (IG) · Bedridden adults with neurological disorders receiving long-term home enteral nutrition; average age 75.2 years
1.01 billion CFU375 mg120 days11
Differential Health Effects on Inflammatory, Immunological and Stress Parameters in Professional Soccer Players and Sedentary Individuals after Consuming a Synbiotic. A Triple-Blinded, Randomized, Placebo-Controlled Pilot Study
2021 · Sedentary participants administered with the synbiotic · Sedentary male students with low physical activity (≤150 min/week)
1 billion CFU200 mg30 days—
Differential Health Effects on Inflammatory, Immunological and Stress Parameters in Professional Soccer Players and Sedentary Individuals after Consuming a Synbiotic. A Triple-Blinded, Randomized, Placebo-Controlled Pilot Study
2021 · Professional soccer players administered with the synbiotic · Male professional soccer players competing in the Spanish Second Division B
1 billion CFU200 mg30 days—
The effects of synbiotic supplementation on blood pressure and other maternal outcomes in pregnant mothers with mild preeclampsia: a triple-blinded randomized controlled trial
2024 · synbiotic group · Pregnant women aged 24 years or older with mild preeclampsia
1 billion CFU——64
A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food, SBD111, for the clinical dietary management of bone loss in menopausal women
2025 · SBD111 · Healthy postmenopausal women 1–6 years after menopause, aged about 55 years; some had osteopenia or BMI ≥30
95 billion CFU1.28 g1 year144
Efficacy of the Synbiotic Supplementation on the Metabolic Factors in Patients with Metabolic Syndrome: A Randomized, Triple-Blind, Placebo-Controlled Trial
2022 · synbiotic · Adults with metabolic syndrome; age range and sex distribution not specified
1 billion CFU77 g12 weeks65
Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease
2020 · synbiotic treatment · Adults with proven nonalcoholic fatty liver disease (NAFLD); ages and sex distribution not specified for this arm
10 billion CFU8 g1 year55
Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: a double-blind randomized controlled trial
2023 · Synbiotic · Healthy adults aged 18–65 years; 66% female in this arm; no stated disease
0.225 billion CFU500 mg8 weeks53
Impact of Synbiotic Intake on Liver Metabolism in Metabolically Healthy Participants and Its Potential Preventive Effect on Metabolic-Dysfunction-Associated Fatty Liver Disease (MAFLD): A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
2024 · synbiotic (SYN) · Men aged 20–60 years, metabolically healthy, with BMI 20–34 kg/m²
2 billion CFU—7 weeks45
Evaluation of Lactocare® Synbiotic Administration on the Serum Electrolytes and Trace Elements Levels in Psoriasis Patients: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial Study
2022 · treatment group · Adults aged 18–60 with mild to moderate psoriasis
2 billion CFU—12 weeks32
The effects of synbiotics on indoxyl sulphate level, constipation, and quality of life associated with constipation in chronic haemodialysis patients: a randomized controlled trial
2022 · Synbiotics · Adults over 18 years old with chronic kidney disease on haemodialysis and gastrointestinal complaints including constipation
10 billion CFU60 mg60 days30
Changes in Gut Microbiota and Systemic Inflammation after Synbiotic Supplementation in Patients with Systemic Lupus Erythematosus: A Randomized, Double-Blind, Placebo-Controlled Trial
2022 · synbiotic-supplemented group · Women aged 18–60 with systemic lupus erythematosus and gastrointestinal symptoms
3 billion CFU80 mg60 days23
Consumption of a new developed synbiotic yogurt improves oxidative stress status in adults with metabolic syndrome: a randomized controlled clinical trial
2024 · Intervention group · Adults aged 30–50 with metabolic syndrome and BMI 25–35 kg/m²
0.2 billion CFU—12 weeks22
Synbiotic Lactobacillus acidophilus NCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: a randomized, double-blinded cross-over trial
2014 · synbiotic · Healthy volunteers; age and sex not reported.
1 billion CFU5 g3 weeks18
Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection
2012 · Synbiotic · Adult women with HIV-1 infection taking antiretroviral medication and with blood CD4 count >200 cells/μl
10 billion CFU2.5 g4 weeks14
Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity
2020 · synbiotic (treatment) group · Adult men and women, mean age 47.4 years, initially overweight or obese (mean BMI 33.5 kg/m²), enrolled in a weight-loss program; participants with gastrointestinal, autoimmune or metabolic diseases and relevant medications were excluded.
15 billion CFU5.5 g90 days10
In school-aged children a combination of galacto-oligosaccharides and Lactobacillus GG increases bifidobacteria more than Lactobacillus GG on its own
2008 · LGG plus GOS · Healthy school-aged children
6.5 billion CFU2 g3 weeks—
Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics
2018 · IVS-1 + GOS · Women and men aged 18–65 years with obesity (BMI 30.0–40.0 kg/m²)
1 billion CFU5 g3 weeks—
Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics
2018 · BB-12 + GOS · Women and men aged 18–65 years with obesity (BMI 30.0–40.0 kg/m²)
1 billion CFU5 g3 weeks—
A synbiotic supplement for inflammation and oxidative stress and lipid abnormalities in hemodialysis patients
2019 · synbiotic group · Hemodialysis patients; age and sex not reported
100 mg—8 weeks—
The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID-19 patients: A randomized placebo-controlled trial
2023 · intervention group · Hospitalized patients with confirmed COVID-19 infection; age and sex not specified
2 billion CFU—2 weeks—
Multi-species synbiotic supplementation increased fecal short chain fatty acids and anti-inflammatory cytokine interleukin-10 in adult men with dyslipidemia; A randomized, double-blind, clinical trial
2024 · synbiotic group · Adult men with dyslipidemia
60 billion CFU10 g12 weeks—
Effects of multi-species synbiotic supplementation on circulating miR-27a, miR-33a levels and lipid parameters in adult men with dyslipidaemia; a randomised, double-blind, placebo-controlled clinical trial
2025 · synbiotic · adult men with dyslipidaemia
60 billion CFU10 g12 weeks—
Beneficial Effects of Synbiotics on the Gut Microbiome in Individuals with Low Fiber Intake: Secondary Analysis of a Double-Blind, Randomized Controlled Trial
2024 · synbiotic (SYN) group · Male non-smokers aged 20–60 without stated disease; secondary analysis stratified participants by low or high baseline fiber intake
2 billion CFU—7 weeks—
The impact of synbiotic on serum sCD163/sTWEAK, paraoxonase 1, and lipoproteins in patients with chronic heart failure: a randomized, triple-blind, controlled trial
2024 · synbiotic group · Adults aged 30–70 with chronic heart failure, LVEF <40%, and NYHA class I–III
30.4 billion CFU38.5 mg10 weeks45
An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients
2021 · Synbiotic (arm S), CKD patients · Adults aged 30–65 with stage IIIb–IV chronic kidney disease, not on dialysis
4.8 billion CFU5 g60 days13
An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients
2021 · Synbiotic (arm S), healthy volunteers · Healthy adults aged 35–60
4.8 billion CFU5 g60 days12
Effects of a Synbiotic on Plasma Immune Activity Markers and Short-Chain Fatty Acids in Children and Adults with ADHD-A Randomized Controlled Trial
2023 · Synbiotic 2000 · Children and adults aged 5–55 with ADHD
400 billion CFU10 g9 weeks—